Evolution of cell & gene therapy in China: the case for universal CAR-T
China now represents 60% of clinical development in CAR-T therapy development globally: what have we learned to date and where are future opportunities?
Driving efficiencies through virtual trial solutions in Asia Pacific
What is driving the acceleration of clinical trials in the Asia Pacific region and what are key considerations to maximise the opportunity for decentralised clinical trials in the future across the region.
Accelerating Clinical Trials in Rare Disease - Understanding Asia’s success as a rare disease clinical trial location
This webinar looks at Asia’s rare disease clinical trial landscape, why China is an increasingly attractive location for rare disease trials and critical program strategies to consider.
Expedited clinical development strategies for China
A two-part webinar interview and panel discussion with exclusive insights into China’s regulatory environment, the advantages of involving China sites, and strategies to accelerate entry in China.
The benefits of running clinical trials in China
During this webinar we will discuss how China offers a significant opportunity for biotech companies to accelerate their clinical development.
